Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol
Irinotecan (CPT11) chemotherapy-induced diarrhea affects a substantial cancer population due to β-glucuronidase (Gus) converting 10-O-glucuronyl-7-ethyl-10-hydroxycamptothecin (SN38G) to toxic 7-ethyl-10-hydroxycamptothecin (SN38). Existing interventions primarily address inflammation and Gus enzyme...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221138352400385X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850113785652576256 |
|---|---|
| author | Ruiyang Gao Bei Yue Cheng Lv Xiaolong Geng Zhilun Yu Hao Wang Beibei Zhang Fangbin Ai Ziyi Wang Donghui Liu Zhengtao Wang Kaixian Chen Wei Dou |
| author_facet | Ruiyang Gao Bei Yue Cheng Lv Xiaolong Geng Zhilun Yu Hao Wang Beibei Zhang Fangbin Ai Ziyi Wang Donghui Liu Zhengtao Wang Kaixian Chen Wei Dou |
| author_sort | Ruiyang Gao |
| collection | DOAJ |
| description | Irinotecan (CPT11) chemotherapy-induced diarrhea affects a substantial cancer population due to β-glucuronidase (Gus) converting 10-O-glucuronyl-7-ethyl-10-hydroxycamptothecin (SN38G) to toxic 7-ethyl-10-hydroxycamptothecin (SN38). Existing interventions primarily address inflammation and Gus enzyme inhibition, neglecting epithelial repair and Gus-expressing bacteria. Herein, we discovered that dehydrodiisoeugenol (DDIE), isolated from nutmeg, alleviates CPT11-induced intestinal mucositis alongside a synergistic antitumor effect with CPT11 by improving weight loss, colon shortening, epithelial barrier dysfunction, goblet cells and intestinal stem cells (ISCs) loss, and wound-healing. The anti-mucositis effect of DDIE is gut microbiota-dependent. Analysis of microbiome profiling data from clinical patients and CPT11-induced mucositis mice reveals a strong correlation between CPT11 chemotoxicity and Gus-expressing bacteria, particularly Enterococcus faecalis (E. faecalis). DDIE counters CPT11-induced augmentation of E. faecalis, leading to decreased intestinal Gus and SN38 levels. The Partial Least Squares Path Model (PLS-PM) algorithm initially links E. faecalis to dysregulated epithelial renovation. This is further validated in a 3D intestinal organoid model, in which both SN38 and E. faecalis hinder the formation and differentiation of organoids. Interestingly, colonization of E. faecalis exacerbates CPT11-induced mucositis and disturbs epithelial differentiation. Our study unveils a microbiota-driven, epithelial reconstruction-mediated action of DDIE against mucositis, proposing the ‘Gus bacteria–host–irinotecan axis’ as a promising target for mitigating CPT11 chemotoxicity. |
| format | Article |
| id | doaj-art-63c49dc06d30498ea5f8dc1eee54a2b0 |
| institution | OA Journals |
| issn | 2211-3835 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj-art-63c49dc06d30498ea5f8dc1eee54a2b02025-08-20T02:37:04ZengElsevierActa Pharmaceutica Sinica B2211-38352024-12-0114125286530410.1016/j.apsb.2024.09.018Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenolRuiyang Gao0Bei Yue1Cheng Lv2Xiaolong Geng3Zhilun Yu4Hao Wang5Beibei Zhang6Fangbin Ai7Ziyi Wang8Donghui Liu9Zhengtao Wang10Kaixian Chen11Wei Dou12The MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaCentre for Chinese Herbal Medicine Drug Development Limited, Hong Kong Baptist University, Hong Kong SAR 999077, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, ChinaThe MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Corresponding authors.The MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201210, China; Corresponding authors.The MOE Key Laboratory of Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines, and the SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Corresponding authors.Irinotecan (CPT11) chemotherapy-induced diarrhea affects a substantial cancer population due to β-glucuronidase (Gus) converting 10-O-glucuronyl-7-ethyl-10-hydroxycamptothecin (SN38G) to toxic 7-ethyl-10-hydroxycamptothecin (SN38). Existing interventions primarily address inflammation and Gus enzyme inhibition, neglecting epithelial repair and Gus-expressing bacteria. Herein, we discovered that dehydrodiisoeugenol (DDIE), isolated from nutmeg, alleviates CPT11-induced intestinal mucositis alongside a synergistic antitumor effect with CPT11 by improving weight loss, colon shortening, epithelial barrier dysfunction, goblet cells and intestinal stem cells (ISCs) loss, and wound-healing. The anti-mucositis effect of DDIE is gut microbiota-dependent. Analysis of microbiome profiling data from clinical patients and CPT11-induced mucositis mice reveals a strong correlation between CPT11 chemotoxicity and Gus-expressing bacteria, particularly Enterococcus faecalis (E. faecalis). DDIE counters CPT11-induced augmentation of E. faecalis, leading to decreased intestinal Gus and SN38 levels. The Partial Least Squares Path Model (PLS-PM) algorithm initially links E. faecalis to dysregulated epithelial renovation. This is further validated in a 3D intestinal organoid model, in which both SN38 and E. faecalis hinder the formation and differentiation of organoids. Interestingly, colonization of E. faecalis exacerbates CPT11-induced mucositis and disturbs epithelial differentiation. Our study unveils a microbiota-driven, epithelial reconstruction-mediated action of DDIE against mucositis, proposing the ‘Gus bacteria–host–irinotecan axis’ as a promising target for mitigating CPT11 chemotoxicity.http://www.sciencedirect.com/science/article/pii/S221138352400385XIrinotecanIntestinal mucositisβ-GlucuronidaseEnterococcus faecalisIntestinal stem cellsEpithelial regeneration |
| spellingShingle | Ruiyang Gao Bei Yue Cheng Lv Xiaolong Geng Zhilun Yu Hao Wang Beibei Zhang Fangbin Ai Ziyi Wang Donghui Liu Zhengtao Wang Kaixian Chen Wei Dou Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol Acta Pharmaceutica Sinica B Irinotecan Intestinal mucositis β-Glucuronidase Enterococcus faecalis Intestinal stem cells Epithelial regeneration |
| title | Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol |
| title_full | Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol |
| title_fullStr | Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol |
| title_full_unstemmed | Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol |
| title_short | Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol |
| title_sort | targeted inhibition of gus expressing enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol |
| topic | Irinotecan Intestinal mucositis β-Glucuronidase Enterococcus faecalis Intestinal stem cells Epithelial regeneration |
| url | http://www.sciencedirect.com/science/article/pii/S221138352400385X |
| work_keys_str_mv | AT ruiyanggao targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT beiyue targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT chenglv targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT xiaolonggeng targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT zhilunyu targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT haowang targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT beibeizhang targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT fangbinai targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT ziyiwang targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT donghuiliu targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT zhengtaowang targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT kaixianchen targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol AT weidou targetedinhibitionofgusexpressingenterococcusfaecalistopromoteintestinalstemcellandepithelialrenovationcontributestothereliefofirinotecanchemotoxicitybydehydrodiisoeugenol |